Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADRB2 | P07550 | 1/20 | 0.45 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.45 |
| ▸ | ADRB3 | P13945 | 1/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
| ▸ | ATM | Q13315 | 1/20 | 0.40 |
| ▸ | TSHR | P16473 | 6/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | HPGD | P15428 | 1/20 | 0.37 |
| ▸ | CA1 | P00915 | 1/20 | 0.36 |
| ▸ | CA2 | P00918 | 1/20 | 0.36 |
| ▸ | THRB | P10828 | 1/20 | 0.35 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.34 |
| ▸ | NAAA | Q02083 | 1/20 | 0.33 |
| ▸ | DGKA | P23743 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
| ▸ | CES2 | O00748 | 1/20 | 0.32 |
| ▸ | ACHE | P22303 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL9709358 | 0.97 | ADRB2 (0.43) | ADRB2ADRB1ADRB3ALDH1A1ATM | |
| SCHEMBL21812049 | 0.94 | ADRB2 (0.41) | ADRB2ADRB1ADRB3ALDH1A1ATM | |
| SCHEMBL17965931 | 0.90 | NAAA (0.42) | TSHRCA1CA2THRBNAAA | |
| SCHEMBL23365026 | 0.88 | TSHR (0.47) | TSHRCA1CA2THRBNAAA | |
| SCHEMBL23365060 | 0.88 | TSHR (0.47) | TSHRCA1CA2THRBNAAA | |
| SCHEMBL3814404 | 0.88 | TSHR (0.47) | TSHRCA1CA2THRBNAAA | |
| SCHEMBL3752170 | 0.85 | ADRB2 (0.39) | ADRB2ADRB1ADRB3ALDH1A1ATM | |
| SCHEMBL21812066 | 0.79 | ATM (0.37) | ADRB2ADRB1ADRB3ALDH1A1ATM | |
| SCHEMBL20816212 | 0.79 | ATM (0.37) | ADRB2ADRB1ADRB3ALDH1A1ATM | |
| SCHEMBL340265 | 0.79 | CA1 (0.30) | CA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 184 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240059571-A1 | SILICA WITH ULTRA-FAST DISSOLUTION PROPERTIES | SIL'INNOV SRCL (BE) | 2024-02-22 | — | — | US | claimed |
| EP-3939573-A1 | DRUG DELIVERY SYSTEM FOR NATURAL PHENOLS | CFG Pharma Srl (BE) | 2022-01-19 | — | — | EP | claimed |
| WO-2021069074-A1 | SILICA WITH ULTRA-FAST DISSOLUTION PROPERTIES | SIL'INNOV SRCL (BE) | 2021-04-15 | — | — | WO | claimed |
| WO-2021069108-A1 | SILICA WITH ULTRA-FAST DISSOLUTION PROPERTIES | SIL'INNOV SRCL (BE) | 2021-04-15 | — | — | WO | claimed |
| EP-3680216-A1 | MESOPOROUS SILICAS AND METHOD FOR SYNTHESISING THEM | Sil'Innov SCRL (BE) | 2020-07-15 | — | — | EP | claimed |
| EP-3445713-B1 | MESOPOROUS SILICAS AND METHOD FOR THE SYNTHESIS THEREOF | SILINNOV SCRL (BE) | 2020-03-18 | — | — | EP | claimed |
| US-20190084836-A1 | Mesoporous Silicas and Method for the Synthesis Thereof | Sil'innov S.c.r.l. (BE) | 2019-03-21 | — | — | US | claimed |
| WO-2017182245-A1 | MESOPOROUS SILICAS AND METHOD FOR THE SYNTHESIS THEREOF | SIL'INNOV SCRL (BE) | 2017-10-26 | — | — | WO | claimed |
| US-7247687-B2 | Late transition metal catalysts for olefin polymerization and oligomerization | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2007-07-24 | — | — | US | claimed |
| EP-1521758-B1 | LATE TRANSITION METAL CATALYSTS FOR OLEFIN POLYMERIZATION AND OLIGOMERIZATION | EXXONMOBIL CHEM PATENTS INC (US) | 2006-05-24 | — | — | EP | claimed |
| US-20060047094-A1 | Late transition metal catalysts for olefin polymerization and oligomerization | EXXONMOBIL CHEMICAL PATENTS INC. | 2006-03-02 | — | — | US | claimed |
| EP-1521758-A1 | LATE TRANSITION METAL CATALYSTS FOR OLEFIN POLYMERIZATION AND OLIGOMERIZATION | Exxonmobil Chemical Patents Inc. (US) | 2005-04-13 | — | — | EP | claimed |
| WO-2004007509-A1 | LATE TRANSITION METAL CATALYSTS FOR OLEFIN POLYMERIZATION AND OLIGOMERIZATION | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2004-01-22 | — | — | WO | claimed |
| CN-110325591-B | Rubber composition and crosslinked rubber | 日本瑞翁株式会社 | 2024-07-09 | — | — | CN | disclosed |
| US-20240132675-A1 | POLYMER HAVING METAL-OXYGEN-METAL BOND AS PRIMARY CHAIN, COMPOSITION THEREOF, SOLID MATERIAL AND PRODUCTION METHOD THEREOF, AND ELECTRONIC COMPONENT AND FIBER | TORAY INDUSTRIES, INC. (JP) | 2024-04-25 | — | — | US | disclosed |
| CN-117590688-A | Curable composition, cured product thereof, and method for producing same | 株式会社钟化 | 2024-02-23 | — | — | CN | disclosed |
| US-5068304-A | Hydrolyzable silyl group containing polyether compound as a curable component joined by urethane groups capable of forming a rubber like substance | ASAHI GLASS COMPANY, LTD. (JP) | 1991-11-26 | — | — | US | disclosed |
| EP-0426774-A1 | SILYL TERMINATED POLYMERS | EASTMAN KODAK COMPANY (US) | 1991-05-15 | — | — | EP | disclosed |
| EP-0372561-A2 | Moisture-curable resin composition | ASAHI GLASS COMPANY LTD. (JP) | 1990-06-13 | — | — | EP | disclosed |
| US-4282145-A | Process for the preparation of azetidines | GIST-BROCADES N.V. (NL) | 1981-08-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060047094-A1 | Late transition metal catalysts for olefin polymerization and oligomerization | MLX, LOX, LMTK3 | ADRB2 2122/4885ADRB1 1580/4885ADRB3 1789/4885 |
| US-20240059571-A1 | SILICA WITH ULTRA-FAST DISSOLUTION PROPERTIES | SI, DDOST, TREH | ADRB2 3352/4885ADRB1 3483/4885ADRB3 3996/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.